Actuated Nucleic Acid Isolation for Equipment-Free Processing

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current nucleic acid detection at point-of-care is hindered by laboratory-based sample processing methods requiring specialized equipment and skilled personnel, limiting its use in resource-limited settings, while nucleic acid-based diagnostics offer higher sensitivity and accuracy than antigen-based tests.

Innovation Solution

A device comprising a housing with a binding chamber and multiple chambers connected by channels, utilizing actuators to convey fluids for nucleic acid isolation without the need for external equipment, allowing for rapid and equipment-free nucleic acid isolation from various samples.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If laboratory-based sample processing methods are used, then nucleic acid isolation accuracy is improved, but device complexity and requirement for specialized equipment increases

Engineering Contradiction:
Improvenucleic acid isolation accuracyVSAvoidrequirement for specialized equipment
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent combines multiple laboratory functions (lysis, binding, washing, elution) into a single integrated device. The binding chamber integrates magnetic bead-based nucleic acid isolation with fluid delivery systems, eliminating the need for separate pipettors, centrifuges, and incubators while maintaining laboratory-grade accuracy.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The device performs multiple functions through a single platform: sample lysis, magnetic bead binding, wash buffer application, and nucleic acid elution. The fluid delivery system can accommodate different buffer types and sample volumes, making the device universally applicable for nucleic acid isolation without requiring multiple specialized tools.

Inventive Principle:
Principle #6Universality (Multi-functionality)

2Measurement precision

If laboratory-based sample processing methods are used, then nucleic acid isolation accuracy is improved, but loss of time increases

Engineering Contradiction:
Improvenucleic acid isolation accuracyVSAvoidprocessing time
Core Design Contradiction:
Measurement precisionVSLoss of time

Solution Approach 1:

The device pre-assembles all necessary components including magnetic beads, binding chambers, and fluid delivery systems before use. Reagents are pre-loaded into the device, and the binding chamber is pre-configured, eliminating the need for time-consuming assembly steps during actual sample processing and reducing overall processing time while maintaining accuracy.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The automated fluid delivery system enables continuous processing without interruption. The system seamlessly transitions between lysis, binding, washing, and elution steps without manual intervention delays, maintaining continuous useful action throughout the nucleic acid isolation process and significantly reducing total processing time compared to manual laboratory methods.

Inventive Principle:
Principle #20Continuity of useful action

3Reliability

If skilled lab personnel are required, then nucleic acid isolation reliability is improved, but ease of operation deteriorates

Engineering Contradiction:
Improvenucleic acid isolation reliabilityVSAvoidease of use
Core Design Contradiction:
ReliabilityVSEase of operation

Solution Approach 1:

The device is designed to perform nucleic acid isolation autonomously without requiring skilled laboratory personnel. The automated fluid delivery system, integrated binding chamber, and pre-configured reagents enable the device to self-perform lysis, binding, washing, and elution steps, making the process as easy as loading the sample while maintaining laboratory-grade reliability.

Inventive Principle:
Principle #25Self-service

Solution Approach 2:

The device acts as an intermediary between the sample and the final nucleic acid extraction. The integrated binding chamber and automated fluid delivery system mediate the complex interaction between reagents and sample, controlling fluid flow, timing, and mixing automatically, thereby eliminating the need for skilled operator intervention while ensuring consistent reliable results.

Inventive Principle:
Principle #24Intermediary (Mediator)

4Productivity

If rapid nucleic acid isolation is achieved, then productivity is improved, but device complexity may increase

Engineering Contradiction:
Improveisolation speedVSAvoiddevice structure
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The device employs pneumatic and hydraulic principles through its automated fluid delivery system. Pressurized fluid delivery and vacuum-assisted magnetic bead separation enable rapid nucleic acid isolation in under 5 minutes. The fluid dynamics-based mechanisms facilitate quick and efficient transfer of reagents and samples, achieving high productivity without requiring complex mechanical moving parts.

Inventive Principle:
Principle #29Pneumatics and hydraulics

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enables rapid nucleic acid isolation in under 5 minutes, eliminating the need for laboratory equipment and skilled personnel, and providing sensitive and accurate diagnostics.

Implementation Method 1

a binding chamber with a binding component capable of binding nucleic acid therein

Methodology Applied
Scientific EffectAdsorption: Adsorption

Data Source

PatentUS20250263689A1Methods and systems for nucleic acid isolation
Publication Date: 2025.08.21 SEEK LABS INC
  • US20250263689A1 patent drawing
  • US20250263689A1 patent drawing
  • US20250263689A1 patent drawing

AI summary

Methods, devices, and systems for isolating nucleic acid e.g., in a point of need setting, featuring a housing with a binding chamber therein, the binding chamber comprising a binding component capable of binding nucleic acid or other molecule or biomolecule of interest, and at least one fluid chamber for housing a sample or other solutions such as but not limited to buffers fluidly connected to the binding chamber. The fluids in the fluid chamber can be conveyed to and from the binding chamber, for example with the use of an actuator.